Research into the shorter and longer term effects of two low-intensity exercise programs in people with type 2 diabetes mellitus (T2DM)

Research into the shorter and longer term effects of two low-intensity exercise programs in people with type 2 diabetes mellitus (T2DM) - effects of two low-intensity exercise programs in people with T2DM

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON56715

Enrollment

Registered

2024-04-09

Start date

2024-04-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes mellitus

Interventions

All participants in the NDC 2024 will receive a digital invitation to participate in the study before the start of the 20-week walking intervention in April. This will take place in September for pa

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: The study population consists of people with T2DM who register for one of the walking interventions in 2024: the national diabetes challenge (20 weeks) or Diabetes in Motion (50 weeks).

Exclusion criteria

Exclusion criteria: In principle, anyone who considers him- or herselve capable of maintaining a walking intervention for a longer period of time can participate. The most important exclusion criterion is inability to maintain the walking intervention.

Design outcomes

Primary

Measure	Time frame
Research is being conducted on the following outcome measures Questionnaires for all participants (A+B): • General questions • Quality of life: WHO-5 and EQ5D5L • Patient activation: PAM-13 • Diabetes management: SDSCA In a subgroup of 60 participants with T2DM (to which this METC application relates; B): • HbA1c • Medication use • Number of contact moments in the general practice in the six months before the measurement moment • Number of steps using Garmin VivoFit 4 • Glucose monitoring using Abbott FreeStyle Libre 2 (see also https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564842/pdf/ijerph-19-12296.pdf ) Primary outcome measures for the 60 participants in the more intensive study (B) are the possible changes: - in number of steps - in glucose regulation - in perceived changes in well-being and quality of life.	—

Measure

Time frame

Research is being conducted on the following outcome measures Questionnaires for all participants (A+B): • General questions • Quality of life: WHO-5 and EQ5D5L • Patient activation: PAM-13 • Diabetes management: SDSCA In a subgroup of 60 participants with T2DM (to which this METC application relates; B): • HbA1c • Medication use • Number of contact moments in the general practice in the six months before the measurement moment • Number of steps using Garmin VivoFit 4 • Glucose monitoring using Abbott FreeStyle Libre 2 (see also https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564842/pdf/ijerph-19-12296.pdf ) Primary outcome measures for the 60 participants in the more intensive study (B) are the possible changes: - in number of steps - in glucose regulation - in perceived changes in well-being and quality of life.

—

Secondary

Measure	Time frame
The other outcome measures mentioned are seen as secondary outcome measures (see above)	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)